1Baum J,Liebermann G, Frenkel EP. The effect of immunologically induced lymphopenia on antibody formation[J]. J Immunol, 1969, 102( 1 ):187-193.
2Sakaguchi S, Sakaguchi N, Asano M, et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanismof self-tolerance causes various autoimmune diseases[J]. J Immunol, 1995, 155(3):1151-1164.
3Hori S,Nomura T,Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3[J]. Science, 2003, 299(5609):1057-1061.
4Hori S,Nomura T,Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3[J]. Science, 2003, 299(5609):1057-1061.
5Khattri R, Kasprowicz D, Cox T, et al. The amount of scurfin protein determines peripheral T cell number and responsiveness[J]. J Immunol, 2001, 167(11):6312-6320.
6Antony PA,Restifo NP.CD4^+CD25^+ T regulatory cells, immunotherapy of cancer, and interleukin-2 [J]. J Immunother, 2005, 28(2):120-128.
7Sasada T, Kimura M, Yoshida Y, et al. CD4^+CD25^+ regulatory T cells in patients with gastrointestinal malignancies: possible involvement of regulatory T cells in disease progression[J]. Cancer, 2003, 98(5):1089-1099.
8Wolf AM, Wolf D, Steurer M, et al. Increase of regulatory T cells in the peripheral blood of cancer patients[J]. Clin Cancer Res, 2003, 9(2):606-612.
9Viguier M, Lemaitre F, Verola O, et al. Foxp3 expressing CD4^+CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells[J]. J Immunol, 2004, 173(2): 1444-1453.
10Berger CL, Tigelaar R, Cohen J, et al. Cutaneous T cell lymphoma: malignant proliferation of T-regulatory cells[J]. Blood, 2005, 105(4): 1640-1647.
2Bates GJ,Fox SB,Han C,et al.Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse[J].J Clin Oncol,2006,24(34):5373-5380.
3Bayer AL,Yu A,Malek TR.Function of the IL-2R for thymic and peripheral CD4+ CD25+ Foxp3+ T regulatory cells[J].J Immunol,2007,178(7):4062-4071.
4Baratelli F,Lee JM,Hazra S,et al.PGE2 contributes to TGF-β induced T regulatory cell function in human non-small cell lung cancer[J].Am J Transl Res,2010,2(4):356-367.
5Corthay A.How do reggulary T cells work[J]? Scandi J Immunol,2009,70(4):326-336.
6Jacobs JF,Idema AJ,Bol KF,et al.Prognostic significance and mechanism of Treg infiltration in human brain tumors[J].J Neuroimmunol,2010,225(1-2):195-199.
7Chen W,Jin W,Hardegen N,et al.Conversion of peripheral CD4+CD25-naive T cells to CD4+CD25+regulatory T cells by TGF-beta induction of transcriptionfactor Foxp3[J].J Exp Med,2003,198(12):1875-1886.
8Biollaz G,Bernasconi L,Cretton C,et al.Site-specific anti-tumor immunity:differences in DC function,TGF-beta production and numbers of intratumoral Foxp3+ Treg[J].Eur J Immunol,2009,39(5):1323-1333.
9Nizar S,Copier J,Meyer B,et al.T-regulatory cell modulation:the future of cancer immunotherapy[J]? Br J Cancer,2009,100(11):1697-1703.
10Fecci PE,Sweeney AE,Grossi PM,et al.Systemic anti-CD25 monoclonal antibody administration safely enhances immunity in murine glioma without eliminating regulatory T cells[J].Clin Cancer Res,2006,12(14 Pt 1):4294-4305.
